Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B

BACKGROUND: Liver biopsy for evaluation of liver fibrosis has several adverse effects, for which reason noninvasive tests have been developed. AIM: To evaluate the usefulness of noninvasive biomarkers, qHBsAg and HBV DNA levels in predicting liver fibrosis in patients with hepatitis Be antigen (HBeA...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Access Maced J Med Sci
Main Authors: Dimzova, Marija, Kondova-Topuzovska, Irena, Bosilkovski, Mile, Ivanovski, Ljubomir, Milenkovic, Zvonko, Semenakova-Cvetkovska, Vesna, Orovcanec, Nikola
Formato: Artigo
Idioma:Inglês
Publicado: Republic of Macedonia 2018
Assuntos:
Clinical Science
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026435/
https://ncbi.nlm.nih.gov/pubmed/29983800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2018.122
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares